To the best of our knowledge, this represents the first identification of CD73 as a cell surface biomarker for ccRCC CSCs and also the first demonstration of the involvement of CD73 in ccRCC progression. The gene discussed is NT5E; the disease is nonpapillary renal cell carcinoma.